Silent Death by Sound: C60 Fullerene Sonodynamic Treatment of Cancer Cells

Int J Mol Sci. 2023 Jan 5;24(2):1020. doi: 10.3390/ijms24021020.

Abstract

The acoustic pressure waves of ultrasound (US) not only penetrate biological tissues deeper than light, but they also generate light emission, termed sonoluminescence. This promoted the idea of its use as an alternative energy source for photosensitizer excitation. Pristine C60 fullerene (C60), an excellent photosensitizer, was explored in the frame of cancer sonodynamic therapy (SDT). For that purpose, we analyzed C60 effects on human cervix carcinoma HeLa cells in combination with a low-intensity US treatment. The time-dependent accumulation of C60 in HeLa cells reached its maximum at 24 h (800 ± 66 ng/106 cells). Half of extranuclear C60 is localized within mitochondria. The efficiency of the C60 nanostructure's sonoexcitation with 1 MHz US was tested with cell-based assays. A significant proapoptotic sonotoxic effect of C60 was found for HeLa cells. C60's ability to induce apoptosis of carcinoma cells after sonoexcitation with US provides a promising novel approach for cancer treatment.

Keywords: C60 fullerene; HeLa cells; apoptosis; sonodynamic therapy; ultrasound.

MeSH terms

  • Carcinoma* / drug therapy
  • Female
  • Fullerenes* / pharmacology
  • HeLa Cells
  • Humans
  • Photochemotherapy*
  • Photosensitizing Agents / pharmacology

Substances

  • Photosensitizing Agents
  • Fullerenes